0001209191-19-061048.txt : 20191217
0001209191-19-061048.hdr.sgml : 20191217
20191217200024
ACCESSION NUMBER: 0001209191-19-061048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191213
FILED AS OF DATE: 20191217
DATE AS OF CHANGE: 20191217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahatme Sandesh
CENTRAL INDEX KEY: 0001511034
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 191291083
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-13
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001511034
Mahatme Sandesh
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
EVP, CFO & CBO
Common Stock
2019-12-13
4
M
0
4319
13.71
A
34498
D
Common Stock
2019-12-13
4
M
0
4138
13.71
A
38636
D
Common Stock
2019-12-13
4
M
0
10466
23.85
A
49102
D
Common Stock
2019-12-13
4
M
0
69479
29.03
A
118581
D
Common Stock
2019-12-13
4
M
0
21875
32.63
A
140456
D
Common Stock
2019-12-13
4
M
0
14723
34.92
A
155179
D
Common Stock
2019-12-13
4
S
0
125000
125.50
D
30179
D
Common Stock
12012
I
By trust
Stock option (right to buy)
13.71
2019-12-13
4
M
0
4319
0.00
D
2017-02-28
2026-02-28
Common Stock
4319
3085
D
Stock option (right to buy)
13.71
2019-12-13
4
M
0
4138
0.00
D
2016-09-09
2026-02-28
Common Stock
4138
2633
D
Stock option (right to buy)
23.85
2019-12-13
4
M
0
10466
0.00
D
2013-11-05
2022-11-05
Common Stock
10466
0
D
Stock option (right to buy)
29.03
2019-12-13
4
M
0
69479
0.00
D
2015-02-28
2024-02-28
Common Stock
69479
0
D
Stock option (right to buy)
32.63
2019-12-13
4
M
0
21875
0.00
D
2018-03-10
2027-03-10
Common Stock
21875
10874
D
Stock option (right to buy)
34.92
2019-12-13
4
M
0
14723
0.00
D
2014-06-04
2023-06-04
Common Stock
14723
39277
D
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
/s/ David Tyronne Howton, as Attorney-in-Fact for Sandesh Mahatme
2019-12-17